Drugs / UI022
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07600385 | Mar 2019 → May 2022 | peripheral arterial disease | Korea United Pharm. Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UI022 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07600385 ↗ |